awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33728406-B961388A-FBB4-4552-9EB2-9C4142AD73FE
Q33728406-B961388A-FBB4-4552-9EB2-9C4142AD73FE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33728406-B961388A-FBB4-4552-9EB2-9C4142AD73FE
Phase I combination of sorafenib and erlotinib therapy in solid tumors: safety, pharmacokinetic, and pharmacodynamic evaluation from an expansion cohort.
P2860
Q33728406-B961388A-FBB4-4552-9EB2-9C4142AD73FE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33728406-B961388A-FBB4-4552-9EB2-9C4142AD73FE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
280f306c82776b5ecdff1f848bb8ef6ada3c37f8
P2860
Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.